Rani Therapeutics Holdings, Inc. · NASDAQ:RANI
Srinivas Akkaraju reported a 9.90% stake in Rani Therapeutics Holdings, Inc. (Schedule 13D)
Event Oct 23, 2025 · Filed Oct 30, 2025
Srinivas Akkaraju reported a 9.90% stake in Rani Therapeutics Holdings, Inc., 9,882,477 shares, with active intent on Oct 23, 2025. Filed Oct 30, 2025 (Schedule 13D).
- Stake
- 9.90%
- Shares
- 9,882,477
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 5.00% | 4,941,239 |
| Samsara BioCapital GP, LLC | 5.00% | 4,941,239 |
| Samsara Opportunity Fund, L.P. | 5.00% | 4,941,238 |
| Samsara Opportunity Fund GP, LLC | 5.00% | 4,941,238 |
| Srinivas Akkaraju | 9.90% | 9,882,477 |
Source
Related
- Rani Therapeutics Holdings, Inc.
- Akkaraju Srinivas
- Rani Therapeutics Holdings, Inc. shareholders
- Schedule 13D/A · Akkaraju Srinivas · May 28, 2026
- Form 4 · Imran Talat · Sep 29, 2026
- Form 4 · Javadi Alireza · Sep 29, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Imran Mir A · Jul 23, 2026